Position in NTLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,068,430
+$2,424,792 QoQ
Shares Held
240,451
+87.5% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 330 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 47%
None 53%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. NTLA ranks #103 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in NTLA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,068,430 | 240,451 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,643,638 | 128,209 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $660,997 | 73,526 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $857,403 | 49,647 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $110,711 | 11,803 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $73,659 | 10,360 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $369,726 | 31,709 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $640,748 | 31,180 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $805,030 | 35,971 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $883,620 | 32,120 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,427,873 | 309,212 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,054,684 | 33,355 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $683,186 | 16,753 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $614,469 | 16,487 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $14,333,577 | 410,822 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $24,341,254 | 434,976 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,436,764 | 414,157 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $31,405,065 | 432,160 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $51,728,815 | 437,490 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $58,593,631 | 436,777 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $35,208,299 | 217,456 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,175,173 | 14,643 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $443,523 | 8,153 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||